20 LATEST RESOURCES (100 INDEXED)
Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on Agomelatine · April 2023
Articles
Neurology and Therapy
Agomelatine in the Treatment of Anhedonia, Somatic Symptoms, and Sexual Dysfunction in Major Depressive Disorder · April 2023
Articles
Frontiers in Psychiatry
The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia · November 2022
Articles
Clinical Psychopharmacology and Neuroscience
Agomelatine, Ketamine and Vortioxetine Attenuate Energy Cell Metabolism: In Vitro Study · November 2022
Articles
International Journal of Molecular Sciences
The Effectiveness of Pregabalin with or without Agomelatine in the Treatment of Chronic Low Back Pain: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial · September 2022
Articles
BMC Pharmacology and Toxicology
Safety and Efficacy of Agomelatine in Children and Adolescents with Major Depressive Disorder Receiving Psychosocial Counselling: A Double-Blind, Randomised, Controlled, Phase 3 Trial in Nine Countries · December 2021
Abstracts
Lancet Psychiatry
Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series · November 2021
Articles
Clinical Psychopharmacology and Neuroscience
Drug Use Evaluation: A Two-Year Retrospective Review of the Effectiveness and Tolerability of Agomelatine versus Mirtazapine in Patients with Depressive Disorder · August 2021
Articles
Brain and Behavior
Agomelatine, a Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model · June 2021
Articles
Frontiers in Psychiatry
Increased Spindle Density Correlates with Sleep Continuity Improvements Following an Eight-Week Course of a Melatonin Agonist in People with Depression: A Proof-of-Concept Study with Agomelatine · June 2021
Abstracts
European Journal of Neuroscience
Agomelatine for Postpartum Depression and Breastfeeding · June 2021
Articles
Therapeutic Advances in Psychopharmacology
The Efficacy and Safety of Agomelatine, Sertraline, and Escitalopram for Senile Post-Stroke Depression: A Randomized Double-Blind Placebo-Controlled Trial · May 2021
Abstracts
Clinical Neurology and Neurosurgery
Suspected Agomelatine-Induced Restless Legs Syndrome: A Case Report · April 2021
Articles
BMC Psychiatry
Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease · March 2021
Articles
Behavioural Neurology
Efficacy of Agomelatine 25-50 Mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies · February 2021
Articles
Advances in Therapy
The Safety of Agomelatine in Standard Medical Practice in Depressed Patients: A 26‐Week International Multicentre Cohort Study · September 2020
Articles
Human Psychopharmacology: Clinical and Experimental
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis · August 2020
Articles
Clinical Psychopharmacology and Neuroscience
Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France · July 2020
Articles
Clinical Drug Investigation